SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase (COIN) is trending due to polarized community reactions to its recent Super Bowl commercial, with sentiment sharply divided on its effectiveness amid broader discussions of significant crypto market volatility. The debate continues on whether the stock has found a bottom or is poised for further declines, alongside anticipation for upcoming earnings.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is drawing significant attention following news of its extended $250 million capital runway through 2028, which many believe secures its operations and removes dilution concerns. The community is sharply divided, with bulls anticipating a short squeeze and another historic surge in the blockchain and molecular-marker technology stock, while skeptics argue it remains a "dilution machine" without sustained product revenue.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as the Super Bowl drives massive betting volume and user engagement, with the community actively debating the company's expanding prediction market offerings and the broader sector's evolving regulatory landscape, all ahead of its anticipated earnings report.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending after abruptly ceasing its compounded GLP-1 weight-loss pill offering amid intensified FDA scrutiny and legal threats, sparking widespread debate about the company's regulatory risks and strategic direction. The community is sharply divided, with bears pointing to management's judgment and potential lawsuits, while bulls emphasize the removal of legal overhang and the broader telehealth platform's potential for recovery and growth, especially with the upcoming Super Bowl ad.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Community excitement for TG Therapeutics is surging following Christina Applegate's Super Bowl commercial for Briumvi, which is expected to drive substantial patient awareness and market adoption. The authentic endorsement is viewed as a significant catalyst, further differentiating Briumvi amidst competitor safety concerns.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

PZZA is trending due to persistent buyout speculation, with community sentiment driven by reports of private equity offers at a premium to its perceived undervalued share price, alongside discussions of activist investor interest and its attractive dividend yield.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is drawing significant attention for its NVIDIA partnership aiming to enhance AI-powered air taxis and ahead of anticipated FAA eIPP city selections, which the community sees as key operational catalysts. Investors are also actively discussing Archer's perceived strengthening position compared to competitors after recent industry capital raises, with BlackRock's increased stake reinforcing confidence in its long-term urban air mobility vision.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is gaining attention after the FDA accepted its New Drug Application for CTx-1301, an ADHD treatment designed for all-day efficacy, setting a PDUFA date of May 31, 2026, with investors also keenly awaiting US patent updates. The community is highly polarized, with many anticipating significant upside due to the large ADHD market and innovative drug delivery, while others express caution regarding potential dilution and market competition.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - VR PRF PERPETUAL USD 100 - Ser A

Strategy Inc Variable Rate Series A Perpetual Stretch Preferred

STRC is trending as it maintains its position around $100 par value, buoyed by its attractive variable dividend rate of 11.25%, with the community actively debating its role in funding MSTR's Bitcoin strategy and its viability as a high-yield income instrument.

SLVO offers the returns of a covered-call strategy comprising long shares of a physical silver ETF (SLV) and short 1-month call options with a strike price of 106% of SLV.

UBS AG London Branch - UBS AG ETRACS Silver Shares Covered Call ETNs

Credit Suisse Silver Shares Cov Call ETN

SLVO is trending as investors anticipate substantial dividends, fueled by a surging silver market and reports of the U.S. Mint halting sales. The community is actively discussing the ETN's covered call strategy, believing it provides attractive income during periods of high volatility despite potentially limiting full upside participation in silver's price rally.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States

Satellos Bioscience Inc. (TSX: MSCL, Nasdaq: MSLE) (Satellos or the Company), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today...

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Satellos Bioscience Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

MSLE
Satellos Bioscience Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MSLE News

MSLESatellos Bioscience Inc